Literature DB >> 19559344

Genetic variants on chromosome 9p21 and ischemic stroke in Chinese.

Wen-li Hu1, Shu-juan Li, Dong-tao Liu, Yan Wang, Shi-qin Niu, Xin-chun Yang, Qi Zhang, Shun-Zhang Yu, Li Jin, Xiao-feng Wang.   

Abstract

In a hospital based case control study, we investigated the association of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, cyclin-dependent kinase inhibitor 2B (CDKN2B) gene, and two genetic variants (rs10757274 and rs2383206) on chromosome region 9p21 with ischemic stroke in Chinese Hans. Two polymorphisms in the CDKN2A gene (rs3088440 and rs3731245) and two polymorphisms in the CDKN2B gene (rs3217992 and rs1063192) were selected by using a strategy of tagging single nucleotide polymorphisms (tSNP). We observed significant association of rs2383206 with ischemic stroke. Subjects with the GG/GA genotype of rs2383206 had a 1.51-fold (95%CI 1.11-2.05, p=0.009) increased risk of stroke, compared with those with the AA genotype. In addition, the GG/GA genotypes of rs2383206 and rs3731245 was associated with an increased risk of large vessel subtype and small vessel subtype of ischemic stroke, respectively, with ORs of 2.09 (95%CI 1.30-3.37, p=0.002) and 1.63 (95%CI 1.06-2.51, p=0.026), respectively. In gene-environmental interaction analysis, elevation of ischemic stroke risk was observed among AG+GG genotype carriers who consume alcohol, smoke cigarette, and have hypertension, with adjusted combined ORs of 2.86(1.51-5.41), 4.30(2.38-7.77), and 13.97(7.78-25.07), respectively, compared with low-risk individuals for rs2383206 (GG carriers who did not consume alcohol, smoke cigarette, and without hypertension). We provide evidence that genetic variants on chromosome region 9p21 may implicated in the prevalence of ischemic stroke in Chinese.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19559344     DOI: 10.1016/j.brainresbull.2009.04.001

Source DB:  PubMed          Journal:  Brain Res Bull        ISSN: 0361-9230            Impact factor:   4.077


  19 in total

1.  Bivariate genetic association of KIAA1797 with heart rate in American Indians: the Strong Heart Family Study.

Authors:  Phillip E Melton; Sue Rutherford; Venkata Saroja Voruganti; Harald H H Göring; Sandra Laston; Karin Haack; Anthony G Comuzzie; Thomas D Dyer; Matthew P Johnson; Jack W Kent; Joanne E Curran; Eric K Moses; John Blangero; Ana Barac; Elisa T Lee; Lyle G Best; Richard R Fabsitz; Richard B Devereux; Peter M Okin; Jonathan N Bella; Uli Broeckel; Barbara V Howard; Jean W MacCluer; Shelley A Cole; Laura Almasy
Journal:  Hum Mol Genet       Date:  2010-07-03       Impact factor: 6.150

2.  Chromosome 9p21.3 Variants Are Associated with Cerebral Infarction in Chinese Population.

Authors:  Xuanye Yue; Lili Tian; Xinying Fan; Gelin Xu; Fu-Dong Shi; Xinfeng Liu
Journal:  J Mol Neurosci       Date:  2015-02-11       Impact factor: 3.444

3.  Chromosome 9p21 in ischemic stroke: population structure and meta-analysis.

Authors:  Christopher D Anderson; Alessandro Biffi; Natalia S Rost; Lynelle Cortellini; Karen L Furie; Jonathan Rosand
Journal:  Stroke       Date:  2010-04-15       Impact factor: 7.914

4.  Effect of 9p21 genetic variation on coronary heart disease is not modified by other risk markers. The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Aaron R Folsom; Vijay Nambi; James S Pankow; Weihong Tang; Kian Farbakhsh; Kazumasa Yamagishi; Eric Boerwinkle
Journal:  Atherosclerosis       Date:  2012-08-18       Impact factor: 5.162

5.  p14ARF genetic polymorphisms and susceptibility to second primary malignancy in patients with index squamous cell carcinoma of the head and neck.

Authors:  Yang Zhang; Erich M Sturgis; Mark E Zafereo; Qingyi Wei; Guojun Li
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

6.  Association of SNPs in CDKN2A (P14ARF) Tumour Suppressor Gene With Endometrial Cancer in Postmenopausal Women.

Authors:  Wioletta Wujcicka; Agnieszka Zajac; Krzysztof Szyllo; Beata Smolarz; Hanna Romanowicz; Grzegorz Stachowiak
Journal:  In Vivo       Date:  2020 Mar-Apr       Impact factor: 2.155

7.  Validated context-dependent associations of coronary heart disease risk with genotype variation in the chromosome 9p21 region: the Atherosclerosis Risk in Communities study.

Authors:  Christine M Lusk; Greg Dyson; Andrew G Clark; Christie M Ballantyne; Ruth Frikke-Schmidt; Anne Tybjærg-Hansen; Eric Boerwinkle; Charles F Sing
Journal:  Hum Genet       Date:  2014-06-03       Impact factor: 4.132

8.  Assessment of the 9p21.3 locus in severity of coronary artery disease in the presence and absence of type 2 diabetes.

Authors:  Natalia V Rivera; Robert Carreras-Torres; Roberta Roncarati; Chiara Viviani-Anselmi; Francesca De Micco; Alessandra Mezzelani; Werner Koch; Petra Hoppmann; Adnan Kastrati; Alexandre F R Stewart; Li Chen; Robert Roberts; Lennart C Karssen; Najaf Amin; Valentina Trimarco; Raffaele Izzo; Guido Iaccarino; Gerolama Condorelli; Annibale A Puca; Paolo Pagnotta; Flavio Airoldi; Bruno Trimarco; Cornelia M van Duijn; Gianluigi Condorelli; Carlo Briguori
Journal:  BMC Med Genet       Date:  2013-01-23       Impact factor: 2.103

9.  Association between 9p21 genomic markers and ischemic stroke risk: evidence based on 21 studies.

Authors:  Xiaoqing Ni; Jiawei Zhang
Journal:  PLoS One       Date:  2014-03-13       Impact factor: 3.240

10.  Association between rs3088440 (G > A) polymorphism at 9p21.3 locus with the occurrence and severity of coronary artery disease in an Iranian population.

Authors:  Mitra Pourgholi; Omid Abazari; Leyla Pourgholi; Maryam Ghasemi-Kasman; Mohammadali Boroumand
Journal:  Mol Biol Rep       Date:  2021-07-27       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.